Literature DB >> 4190350

Intravascular coagulation in acute hepatic necrosis.

M O Rake, P T Flute, G Pannell, R Williams.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 4190350     DOI： 10.1016/s0140-6736(70)90767-1

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  31 in total

1.  Factor VIII levels during the course of acute hepatitis in a haemophiliac.

Authors:  B G Gazzard; R Clark; P T Flute; R Williams
Journal:  J Clin Pathol       Date:  1975-12       Impact factor: 3.411

Review 2.  Acute liver failure.

Authors:  R D Hughes; J Wendon; A E Gimson
Journal:  Gut       Date:  1991-09       Impact factor: 23.059

3.  Behaviour of 125I-fibrinogen and 131I-albumin in experimental galactosamine-induced hepatitis.

Authors:  I Mahn; H Merkel; E L Sattler; G Müller-Berghaus
Journal:  Gut       Date:  1977-07       Impact factor: 23.059

Review 4.  Some clinical features of liver cell failure: an appraisal of their causes.

Authors:  A E Read
Journal:  Gut       Date:  1978-06       Impact factor: 23.059

5.  Fibronectin and Kupffer cell function in fulminant hepatic failure.

Authors:  M Imawari; R D Hughes; C D Gove; R Williams
Journal:  Dig Dis Sci       Date:  1985-11       Impact factor: 3.199

6.  The fibrinolytic enzyme system in hepatic cirrhosis and malignant metastases.

Authors:  D Ogston; N B Bennett; C M Ogston
Journal:  J Clin Pathol       Date:  1971-12       Impact factor: 3.411

Review 7.  Pivotal role of ADAMTS13 function in liver diseases.

Authors:  Masahito Uemura; Yoshihiro Fujimura; Saiho Ko; Masanori Matsumoto; Yoshiyuki Nakajima; Hiroshi Fukui
Journal:  Int J Hematol       Date:  2010-01       Impact factor: 2.490

Review 8.  Indications and criteria for liver transplantation for fulminant hepatic failure.

Authors:  Kenji Fujiwara; Satoshi Mochida
Journal:  J Gastroenterol       Date:  2002       Impact factor: 7.527

9.  Antithrombin III concentrate in the treatment of fulminant hepatic failure.

Authors:  K Fujiwara; K Okita; K Akamatsu; H Abe; Y Tameda; T Sakai; N Inoue; K Kanai; N Aoki; H Oka
Journal:  Gastroenterol Jpn       Date:  1988-08

10.  Antithrombin III metabolism in patients with liver disease.

Authors:  E Knot; J W Ten Cate; H R Drijfhout; L H Kahlé; G N Tytgat
Journal:  J Clin Pathol       Date:  1984-05       Impact factor: 3.411
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.